Heivero Pharmaceuticals Limited
About Heivero Pharmaceuticals Limited
Data last updated:
Heivero Pharmaceuticals Limited is a public limited company based in Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 August 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24231UP1992PLC014636. The company has 3 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹175 Cr and a paid-up capital of ₹14.54 Cr. It is led by directors including Surendra Singh and Ram Kishor Prajapati.
Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at F – 7 To 18 Sector – 21 Industrial Area Jagdispur Sultanpur, Uttar Pradesh, India – 227817.
As per the financials filed for FY 2018, the company reported a revenue of ₹4.25 Lakh. For the same year it recorded a net loss of ₹73,424 (net margin -17.3%) and EBITDA of -₹73,194 (EBITDA margin -17.2%).
Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Heivero Pharmaceuticals Limited's registered office is in Uttar Pradesh.
- Registered AddressF – 7 To 18 Sector – 21 Industrial Area Jagdispur Sultanpur, Uttar Pradesh, India – 227817
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Heivero Pharmaceuticals Limited
FY 2018 filings availableHeivero Pharmaceuticals Limited reported revenue of ₹4.25 Lakh for FY 2018.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹73,194 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹73,424 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -17.2% | |||
| Net Profit Margin | -17.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Heivero Pharmaceuticals Limited, buy the company report.
Board of directors of Heivero Pharmaceuticals Limited
Heivero Pharmaceuticals has 4 current directors and 19 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surendra Singh | Additional Director | 23 May 2016 | 10 Years 5 Months | Current |
| Ram Kishor Prajapati | Additional Director | 23 May 2016 | 10 Years 5 Months | Current |
| Pashupati Nath Dixit | Additional Director | 02 Sep 2018 | 8 Years 1 Months | Current |
| Rajesh Singh Yadav | Additional Director | 23 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Heivero Pharmaceuticals Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medwock Pharmaceuticals Private Limited | ₹4.28 Lakh (FY 2020) | New Delhi, Delhi, India | ||||
| Timetech Formulations Limited | ₹4.27 Lakh (FY 2016) | Hyderabad, Telangana, India | ||||
| Prophends Pharmaceuticals (OPC) Private Limited | ₹4.26 Lakh (FY 2025) | 55.0% | Patna, Bihar, India | |||
| Glorywarrior Pharmaceuticals (OPC) Private Limited | ₹4.26 Lakh (FY 2022) | Ratnagiri, Maharashtra, India | ||||
| Aptaas Pharmaceuticals Private Limited | ₹4.25 Lakh (FY 2018) | -6.0% | New Delhi, Delhi, India | |||
| Heivero Pharmaceuticals Limitedthis company | ₹4.25 Lakh (FY 2018) | -₹73,424 | -17.3% | Uttar Pradesh, India | ||
| Sunchoice Pharmaceuticals Private Limited | ₹4.24 Lakh (FY 2024) | -5.0% | Moradabad, Uttar Pradesh, India | |||
| Ebullition Pharmaceuticals Private Limited | ₹4.23 Lakh (FY 2022) | -46.0% | New Delhi, Delhi, India | |||
| Lanz Labs Private Limited | ₹4.23 Lakh (FY 2025) | 1672.0% | Mumbai, Maharashtra, India | |||
| Smark Pharmaceuticals Private Limited | ₹4.23 Lakh (FY 2025) | -2.0% | Uttar Pradesh, India | |||
| Rabindra Pharmaceuticals Private Limited | ₹4.22 Lakh (FY 2025) | -60.0% | Muzaffarpur, Bihar, India |
To see the full peer comparison of Heivero Pharmaceuticals Limited, buy the company report.
Legal cases
Heivero Pharmaceuticals Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ranchi, Jharkhand | Court case (Regular CBI) | Filed against the company by an individual | Pending |
| District court, Kamrup Metro, Assam | Court case (Special PMLA) | Filed against the company by an individual | Disposed |
To see the full case history of Heivero Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Heivero Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Heivero Pharmaceuticals has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Heivero Pharmaceuticals Limited, buy the company report.
Recent activity
Heivero Pharmaceuticals Limited has 23 board changes on record since 2009: 4 appointments and 19 cessations. The latest: Pashupati Nath Dixit was appointed as Additional Director on 02 Sep 2018.
14 earlier events are in the company report.
Frequently asked questions
Heivero Pharmaceuticals is an active public limited company based in Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 August 1992 (34+ years old) and is registered under CIN U24231UP1992PLC014636.
Heivero Pharmaceuticals has 4 current directors:
- Surendra Singh - Additional Director
- Ram Kishor Prajapati - Additional Director
- Pashupati Nath Dixit - Additional Director
- Rajesh Singh Yadav - Additional Director
The latest financial statements of Heivero Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from 2015 are in the company report.
No. Heivero Pharmaceuticals has 3 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Heivero Pharmaceuticals is U24231UP1992PLC014636. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Heivero Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending.
Heivero Pharmaceuticals was incorporated on 11 August 1992, making it 34+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Heivero Pharmaceuticals by revenue are Medwock Pharmaceuticals Private Limited, Timetech Formulations Limited, Prophends Pharmaceuticals (OPC) Private Limited, Glorywarrior Pharmaceuticals (OPC) Private Limited, Aptaas Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Pashupati Nath Dixit was appointed as Additional Director on 02 Sep 2018. Pashupati Nath Dixit ceased to be Additional Director on 30 May 2016. Rajesh Kumar Sharma ceased to be Additional Director on 30 May 2016. Heivero Pharmaceuticals has 23 board changes on record in total.
The registered office of Heivero Pharmaceuticals is at F – 7 To 18 Sector – 21 Industrial Area Jagdispur Sultanpur, Uttar Pradesh, India – 227817.
Heivero Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.